GSK to Market Enigma Diagnostics' POC Respiratory Disease Tests Under New Pact
August 10, 2011
GSK to Market Enigma Diagnostics' POC Respiratory Disease Tests Under New Pact
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Enigma Dx Begins Clinical Trials for Flu Test on Integrated MDx Platform
April 14, 2011 / PCR Insider - Enigma and Tecan Expand OEM Pact to Develop High-Throughput MDx Platform for Third Party
January 13, 2011 / PCR Insider - Enigma Diagnostics Taps Tecan to Make and Market Forthcoming POC Molecular Dx Platform
February 11, 2010 / PCR Insider - Enigma, GSK Sign Infectious Disease Testing Pact
August 10, 2011 / GenomeWeb Daily News - Enigma Wraps Up EU-Funded Consortium to Develop Seasonal Flu MDx
July 19, 2011 / PCR Insider